UA87982C2 - Способ лечения или предотвращения расстройств центральной нервной системы производными 1-ар(алк)-4-пиперидиноимидазолин-2-она, фармацевтическая композиция - Google Patents
Способ лечения или предотвращения расстройств центральной нервной системы производными 1-ар(алк)-4-пиперидиноимидазолин-2-она, фармацевтическая композицияInfo
- Publication number
- UA87982C2 UA87982C2 UAA200600251A UAA200600251A UA87982C2 UA 87982 C2 UA87982 C2 UA 87982C2 UA A200600251 A UAA200600251 A UA A200600251A UA A200600251 A UAA200600251 A UA A200600251A UA 87982 C2 UA87982 C2 UA 87982C2
- Authority
- UA
- Ukraine
- Prior art keywords
- nervous system
- central nervous
- subunit
- selectivity
- alpha
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48667803P | 2003-07-11 | 2003-07-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA87982C2 true UA87982C2 (ru) | 2009-09-10 |
Family
ID=34062138
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200600251A UA87982C2 (ru) | 2003-07-11 | 2004-06-28 | Способ лечения или предотвращения расстройств центральной нервной системы производными 1-ар(алк)-4-пиперидиноимидазолин-2-она, фармацевтическая композиция |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US20050032863A1 (ru) |
| EP (2) | EP2027856A1 (ru) |
| JP (1) | JP2009513539A (ru) |
| KR (1) | KR20060032633A (ru) |
| CN (2) | CN101254189A (ru) |
| AR (1) | AR045013A1 (ru) |
| AU (1) | AU2004255414A1 (ru) |
| BR (1) | BRPI0412512A (ru) |
| CA (1) | CA2531861A1 (ru) |
| MX (1) | MXPA05013196A (ru) |
| NO (1) | NO20060686L (ru) |
| NZ (1) | NZ544251A (ru) |
| RU (1) | RU2354377C2 (ru) |
| TW (1) | TW200512197A (ru) |
| UA (1) | UA87982C2 (ru) |
| WO (1) | WO2005004867A2 (ru) |
| ZA (1) | ZA200509169B (ru) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101395142B (zh) * | 2006-03-08 | 2012-03-28 | 弗·哈夫曼-拉罗切有限公司 | 4-氨基-1,5-取代的1,5-二氢-咪唑-2-酮 |
| RU2012114770A (ru) | 2009-09-04 | 2013-10-10 | Вандербилт Юниверсити | АЛЛОСТЕРИЧЕСКИЕ СРЕДСТВА ПОТЕНЦИРОВАНИЯ mGluR4, КОМПОЗИЦИИ И СПОСОБЫ ЛЕЧЕНИЯ НЕВРОЛОГИЧЕСКИХ ДИСФУНКЦИЙ |
| AR089645A1 (es) | 2011-08-12 | 2014-09-10 | Boehringer Ingelheim Vetmed | Particula multicapas de sabor enmascarado, metodo, uso, composicion farmaceutica |
| CN104199105A (zh) * | 2014-08-27 | 2014-12-10 | 中国石油天然气集团公司 | 高密度三维勘探中初至的拾取方法及拾取装置 |
| US20190290182A1 (en) * | 2016-07-11 | 2019-09-26 | Ranvier Health Limited | Method of diagnostic relevance based on taste recognition |
| AU2020326244B2 (en) * | 2019-08-06 | 2025-06-05 | Initiator Pharma A/S | Compound for combination treatment |
| KR102489109B1 (ko) * | 2020-06-02 | 2023-01-16 | 부산대학교 산학협력단 | 아세틸콜린 수용체 변이 유전자를 유효성분으로 포함하는 근긴장 이상증 치료용 조성물 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI90869C (fi) * | 1986-11-14 | 1994-04-11 | Tanabe Seiyaku Co | Menetelmä lääkeaineena käyttökelpoisten imidatsolidinonijohdannaisten valmistamiseksi |
| IL104853A (en) * | 1992-02-27 | 1997-11-20 | Yamanouchi Pharma Co Ltd | Benzodiazepine derivatives, their preparation and pharmaceutical compositions containing them |
| US5484944A (en) * | 1993-10-27 | 1996-01-16 | Neurogen Corporation | Certain fused pyrrolecarboxanilides and their use as GABA brain receptor ligands |
| AU5884696A (en) | 1995-06-23 | 1997-01-22 | Bausch & Lomb Incorporated | Method for cleaning contact lenses utilizing polysulfonates |
| DE19532668A1 (de) * | 1995-09-05 | 1997-03-06 | Dresden Arzneimittel | Neue, antikonvulsiv wirkende 1-Ar(alk)yl-imidazolin-2-one, die in 4-Stellung einen disubstituierten Amin-Rest enthalten, und Verfahren zu deren Herstellung |
| US5869481A (en) | 1995-09-05 | 1999-02-09 | Arzneitmittelwerk Dresden G.M.B.H. | Anticonvulsive 1-ar(alk)ylimidazolin-2-ones and process for making |
| US5861423A (en) * | 1997-02-21 | 1999-01-19 | Caldwell; William Scott | Pharmaceutical compositions incorporating aryl substituted olefinic amine compounds |
| DE19721580A1 (de) * | 1997-05-23 | 1998-11-26 | Dresden Arzneimittel | Verwendung von 1-Ar(alk)yl-imidazolin-2-one zur Behandlung von Angst- und Spannungszuständen |
| WO1999037370A1 (en) | 1998-01-22 | 1999-07-29 | Precedence Publishing, Inc. | Game using collectibles as playing pieces |
| GB9821179D0 (en) | 1998-09-30 | 1998-11-25 | Merck Sharp & Dohme | Therapeutic use |
| GB9929687D0 (en) | 1999-12-15 | 2000-02-09 | Merck Sharp & Dohme | Therapeutic agents |
| GB0018473D0 (en) | 2000-07-27 | 2000-09-13 | Merck Sharp & Dohme | Therapeutic agents |
| GB0122696D0 (en) * | 2001-09-20 | 2001-11-14 | Merck Sharp & Dohme | Therapeutic agents |
| US20050070537A1 (en) * | 2002-10-10 | 2005-03-31 | Chris Rundfeldt | Use of dihydroimidazolones for the treatment of dogs |
-
2004
- 2004-06-28 EP EP08168609A patent/EP2027856A1/en not_active Withdrawn
- 2004-06-28 AU AU2004255414A patent/AU2004255414A1/en not_active Abandoned
- 2004-06-28 NZ NZ544251A patent/NZ544251A/en unknown
- 2004-06-28 CA CA002531861A patent/CA2531861A1/en not_active Abandoned
- 2004-06-28 BR BRPI0412512-6A patent/BRPI0412512A/pt not_active IP Right Cessation
- 2004-06-28 KR KR1020067000739A patent/KR20060032633A/ko not_active Ceased
- 2004-06-28 CN CNA200710169458XA patent/CN101254189A/zh active Pending
- 2004-06-28 MX MXPA05013196A patent/MXPA05013196A/es unknown
- 2004-06-28 CN CNA2004800199698A patent/CN1822836A/zh active Pending
- 2004-06-28 EP EP04740387A patent/EP1646386A2/en not_active Withdrawn
- 2004-06-28 RU RU2006104118/14A patent/RU2354377C2/ru not_active IP Right Cessation
- 2004-06-28 JP JP2006519793A patent/JP2009513539A/ja not_active Withdrawn
- 2004-06-28 WO PCT/EP2004/006989 patent/WO2005004867A2/en not_active Ceased
- 2004-06-28 UA UAA200600251A patent/UA87982C2/ru unknown
- 2004-06-28 US US10/878,987 patent/US20050032863A1/en not_active Abandoned
- 2004-06-29 TW TW093119215A patent/TW200512197A/zh unknown
- 2004-07-02 AR ARP040102355A patent/AR045013A1/es unknown
-
2005
- 2005-11-14 ZA ZA200509169A patent/ZA200509169B/xx unknown
-
2006
- 2006-02-13 NO NO20060686A patent/NO20060686L/no not_active Application Discontinuation
-
2007
- 2007-10-29 US US11/978,362 patent/US20080114032A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2009513539A (ja) | 2009-04-02 |
| AR045013A1 (es) | 2005-10-12 |
| ZA200509169B (en) | 2006-07-26 |
| US20050032863A1 (en) | 2005-02-10 |
| KR20060032633A (ko) | 2006-04-17 |
| NO20060686L (no) | 2006-03-14 |
| NZ544251A (en) | 2009-12-24 |
| MXPA05013196A (es) | 2006-03-09 |
| AU2004255414A1 (en) | 2005-01-20 |
| EP1646386A2 (en) | 2006-04-19 |
| CN1822836A (zh) | 2006-08-23 |
| CN101254189A (zh) | 2008-09-03 |
| RU2006104118A (ru) | 2006-06-10 |
| EP2027856A1 (en) | 2009-02-25 |
| RU2354377C2 (ru) | 2009-05-10 |
| CA2531861A1 (en) | 2005-01-20 |
| US20080114032A1 (en) | 2008-05-15 |
| WO2005004867A2 (en) | 2005-01-20 |
| BRPI0412512A (pt) | 2006-09-19 |
| TW200512197A (en) | 2005-04-01 |
| WO2005004867A3 (en) | 2005-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LTC1971601I2 (ru) | ||
| AU2003249983A8 (en) | Piperidines useful for the treatment of central nervous system disorders | |
| TNSN06053A1 (en) | 6-substituted anilino purines as rtk inhibitors | |
| WO2006105516A3 (en) | Compositions and methods for diagnosing and treating neuropsychiatric disorders | |
| BR0200283A (pt) | Composições farmacêuticas para o tratamento de distúrbios do snc e de outros distúrbios | |
| MXPA04006280A (es) | Compuestos espiroazaciclicos como moduladores de receptor de monoamina. | |
| TW200509958A (en) | Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines | |
| TW200531680A (en) | Therapy using 1-aminocyclohexane derivatives for the treatment of behavioral disorders associated with alzheimer's disease | |
| TW200633986A (en) | Therapeutic agents | |
| DE60227576D1 (de) | 3,6-DISUBSTITUIERTE AZABICYCLO i3.1.0 -HEXANDERIVATIVE ALS ANTAGONISTEN DES MUSCARINREZEPTORS | |
| UA87982C2 (ru) | Способ лечения или предотвращения расстройств центральной нервной системы производными 1-ар(алк)-4-пиперидиноимидазолин-2-она, фармацевтическая композиция | |
| CY1107437T1 (el) | Νεα πολυπεπτιδια kcnq και οι χρησεις τους στη διαγνωση διανοητικων διαταραχων | |
| ATE402704T1 (de) | Dopamin-d3-rezeptor-liganden zur behandlung von sucht | |
| MX2007006754A (es) | Derivados de indenilo y uso de los mismos para el tratamiento de trastornos neurologicos. | |
| DE602004013540D1 (de) | Hemmung des cd95 liganden/rezeptor-systems zur behandlung von neurologischen erkrankungen und verletzungen | |
| TW200604154A (en) | Norbornane based cycloaliphatic compounds containing methylene amine groups | |
| EP1976525A4 (en) | PIPERIDINE AND PIPERAZINE DERIVATIVES | |
| PL1978959T3 (pl) | Pochodne piperydyny i piperazyny | |
| SV2006002304A (es) | "azabenzoxazoles para el tratamiento de trastornos del snc" ref.pc32518a | |
| UA85198C2 (ru) | Производные морфолина как ингибиторы повторного поглощения норэпинефрина | |
| HRP20030956A2 (en) | USE OF 1,2-DIAZA-DIBENZO[e,h]AZULENES FOR THE MANU | |
| HK1083315A (en) | Method of treating or preventing central nervous system disorders with compounds having selectivity for the alpha 3 subunit of the benzodiazepine receptor | |
| WO2004058154A3 (en) | Method of identifying therapeutic agents | |
| HRP20030959A2 (ru) | ||
| WO2004020455A3 (en) | Genes involved in neuropsychiatric disorders |